Immunomodulatory activity of dipeptidyl peptidase‐4 inhibitors in immune‐related diseases
M Drakul, M Čolić - European Journal of Immunology, 2023 - Wiley Online Library
Abstract Dipeptidyl peptidase‐4 (DPP‐4), also known as CD26, is a 110‐kDa cell surface
glycoprotein with enzymatic and signal transducing activity. DPP‐4/CD26 is expressed by …
glycoprotein with enzymatic and signal transducing activity. DPP‐4/CD26 is expressed by …
Potential use of sodium glucose co-transporter 2 inhibitors during acute illness: a systematic review based on COVID-19
C Tisch, E Xourgia, A Exadaktylos, M Ziaka - Endocrine, 2024 - Springer
Objective SGLT-2i are increasingly recognized for their benefits in patients with
cardiometabolic risk factors. Additionally, emerging evidence suggests potential applications …
cardiometabolic risk factors. Additionally, emerging evidence suggests potential applications …
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review
K Asadipooya, A Asadipooya, R Adatorwovor - Archives of Virology, 2024 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is still causing hospitalization and death,
and vaccination appears to become less effective with each emerging variant. Spike, non …
and vaccination appears to become less effective with each emerging variant. Spike, non …
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies
ZH Song, QM Huang, SS Xu, JB Zhou… - Therapeutic Innovation & …, 2024 - Springer
Background Diabetes, a chronic disease worldwide, may be associated with a poorer
prognosis in patients with coronavirus disease 2019 (COVID-19). While some …
prognosis in patients with coronavirus disease 2019 (COVID-19). While some …
[HTML][HTML] The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19 mortality in patients with diabetes: A systematic review and meta …
The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19
mortality in patients with diabetes: A systematic review and meta‐analysis - PMC Back to Top …
mortality in patients with diabetes: A systematic review and meta‐analysis - PMC Back to Top …
SGLT2 Inhibitors in COVID-19: Umbrella Review, Meta-analysis, and Bayesian Sensitivity Assessment
Background: Several studies have reported a reduced risk of COVID-19-related mortality in
patients taking antidiabetic medications. This is an umbrella review, meta-analysis, and …
patients taking antidiabetic medications. This is an umbrella review, meta-analysis, and …
Authors' reply to correspondence to" Mortality-related risk factors of inpatients with diabetes and COVID-19: A multicenter retrospective study in Belgium. Ann …
L Orioli, T Servais, L Crenier, P Oriot… - Annales d' …, 2023 - pubmed.ncbi.nlm.nih.gov
Authors' reply to correspondence to "Mortality-related risk factors of inpatients with diabetes
and COVID-19: A multicenter retrospective study in Belgium. Ann Endocrinol (Paris). 2023 …
and COVID-19: A multicenter retrospective study in Belgium. Ann Endocrinol (Paris). 2023 …
[PDF][PDF] САХАРОСНИЖАЮЩАЯ ТЕРАПИЯ У КОМОРБИДНЫХ ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ 2 ТИПА И ОСТРЫМ РЕСПИРАТОРНЫМ …
ЛГ Витько, НВ Стрельникова, НН Масалова… - eport.fesmu.ru
Пациенты с сахарным диабетом входят в категорию высокого риска инфицирования
вирусом SARS-CoV-2, тяжелого течения болезни и смертельного исхода …
вирусом SARS-CoV-2, тяжелого течения болезни и смертельного исхода …
[引用][C] ПРОГНОСТИЧЕСКИЕ ФАКТОРЫ РИСКА НЕБЛАГОПРИЯТНЫХ ИСХОДОВ У ГОСПИТАЛИЗИРОВАННЫХ БОЛЬНЫХ САХАРНЫМ ДИАБЕТОМ 2 ТИПА И …
ТН Маркова